Cannabis Law Report

JANUARY 31, 2022

Numinus Bioscience said that it is prepared to supply psilocybin in whole mushroom form, through three packaged doses equivalent to 10, 15, and 25mg of psilocybin. At this time, Numinus Bioscience said that it is prepared to supply psilocybin in whole mushroom form, through three packaged doses equivalent to 10, 15, and 25mg of psilocybin.

Research and Development 52

Research and Development Clinical Trials Packaging Access 52

Cannabis Law Report

DECEMBER 26, 2021

The patent relates to improved technology for detection and maintenance of the optimal therapeutic psychedelic state, which Entheon intends to study through the monitoring of electroencephalogram (EEG) biomarkers in order to optimize the treatment of neuropsychiatric conditions. US Provisional Patent Filed. About Entheon Biomedical Corp.

Research and Development 52

Research and Development Clinical Trials Treatment Packaging 52

MMJ Recs

MARCH 23, 2024

Legalization may offer expanded access to medical cannabis for patients suffering from various conditions, providing alternative treatment options and symptom relief. However, there are worries about increased cannabis use, particularly among young people, and potential impacts on mental health and road safety.

Legalization 52

Legalization Access Programs Education 52

Cannabis Law Report

FEBRUARY 26, 2022

The organization has, they say, ……evaluated patient access, affordability, equity, and product safety. With a decline in legislative improvements in state medical cannabis programs, millions of patients are left with limited or no access,” ASA Executive Director Debbie Churgai said. “It Pennsylvania State Rep.

Access 98

Access Law Patients Programs 98

CannaMD

SEPTEMBER 15, 2020

Current Florida medical marijuana patient? SHORT ANSWER: In November 2016, the Florida Medical Marijuana Legalization Initiative (known as Amendment 2 ) legalized medical marijuana treatment in Florida. The governor also signed Senate Bill 1700 to protect the privacy of doctors recommending low-THC marijuana and their patients.

Law 126

Law Marijuana Patients Treatment 126

Cannabis Law Report

SEPTEMBER 15, 2021

This deceptive marketing of unproven treatments raises significant public health concerns because patients and other consumers may use them instead of approved therapies to treat serious and even fatal diseases. Of the 22 patients, 19 experienced adverse events after ingesting delta-8 THC-containing food products (e.g.,

THC 105

THC Pets Events Hemp 105

Canna Law Blog

APRIL 27, 2020

According to the FDA’s press release : The opioid crisis continues to be a serious problem in the United States, and we will continue to crack down on companies that attempt to benefit from selling products with unfounded treatment claims,” said FDA Principal Deputy Commissioner Amy Abernethy, M.D.,

CBD 58

CBD Topical Oil Treatment 58

Cannabis Law Report

JANUARY 24, 2020

Currently very limited in its nature, MCAP is only open to patients with spasticity associated with multiple sclerosis and intractable nausea and vomiting associated with chemotherapy that doesn’t respond to conventional treatments. Additionally, severe refractory (treatment-resistant) epilepsy also qualifies.

Oil 59

Oil Epilepsy Conditions Treatment 59

The Blunt Truth

DECEMBER 4, 2019

Specifically, the bill proposes to make it unlawful for an employer to take adverse action against an applicant or employee who is a qualified patient using medical marijuana consistent with state law, unless the position held or sought is one involving “safety-sensitive job duties.” The direct care of a patient or child.

Marijuana 65

Marijuana Safety Packaging State Laws 65

Cannabis Law Report

SEPTEMBER 22, 2022

SB 1186– Medicinal Cannabis Patients’ Right of Access Act. The bill’s author, Senator Scott Weiner, states this bill is a victory for seniors living with chronic illness, and will both improve patient access and help fill voids throughout the state where no cannabis license types have been authorized.

Law 52

Law Events Packaging Pets 52

Cannabis Law Report

FEBRUARY 17, 2022

WORCESTER – The Cannabis Control Commission (Commission) is alerting patients and consumers to its quarantine order (Order), issued October 18, 2021, mandating that ACK Natural, LLC, a colocated medical- and adult-use licensee, recall all products with unverifiable mycotoxin test results sold to its consumers and patients.

Marijuana 52

Marijuana Seed-To-Sale Safety Patients 52

Medicinal Genomics

JANUARY 10, 2024

Since then, CannMed has transformed into an industry event that attracts the brightest minds in cannabis science, medicine, cultivation, and safety testing. Whether it is a newly discovered compound, a destructive plant pathogen, a better treatment protocol, or updated testing standards, the cannabis industry is constantly changing.

Research and Development 52

Research and Development Events Education Medicine 52

Cannabis Law Report

JULY 19, 2021

We are in a mental health crisis and its critical to ensure that we conduct clinical trials to demonstrate safety, and efficacy up to and including phase 3 large scale clinical trials. Extensive early phase experience with appropriate safety oversight and early phase clinic.

Clinical Trials 98

Clinical Trials Research and Development Hybrid Medicine 98

Cannabis Law Report

DECEMBER 6, 2019

Specifically, the bill proposes to make it unlawful for an employer to take adverse action against an applicant or employee who is a qualified patient using medical marijuana consistent with state law, unless the position held or sought is one involving “safety-sensitive job duties.” The direct care of a patient or child.

Marijuana 45

Marijuana Safety Packaging Law 45

Cannabis Law Report

OCTOBER 6, 2021

The focus of this study will be on the use of cannabinoids in patients suffering from Fibromyalgia or chronic pain, with the primary research sites located in the United States and the United Kingdom.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Events 52

Cannabis Law Report

JULY 23, 2019

Businesses preparing to market a new product nationally must follow the rules of trademark law as well as marketing and advertising claims under state and US laws when creating a trademark, advertising copy and copyright-registered packaging for the product. This is particularly the case for cannabis and cannabidiol (CBD) products.

Law 40

Law Clinical Trials CBD Edibles 40

Cannabis Law Report

SEPTEMBER 23, 2021

Because these products concentrate delta-8 THC in amounts much higher than found naturally occurring in the plant, the FDA notes historical cannabis data cannot be relied upon for safety indicators. Final Thoughts & Take-Aways.

THC 52

THC Concentrates Pets DEA 52

Cannabis Law Report

JULY 30, 2019

The ASA highlights that it takes the FDA “an average of 9 years to approve any drug, but it only takes approximately two to four weeks for a medical cannabis patient with chronic pain to be approved by a state program.” ” These patients then have access to purchasing the substance from a regulated state dispensary.

Marijuana 40

Marijuana Education Patients Research and Development 40

The Joint Blog

MAY 19, 2020

The truth is that cannabis is, for many people, an extremely important treatment that’s set to become mainstream. If you’ve had to do a lot of research to understand marijuana, THC, CBD, and hemp, then you can bet that your patients don’t often have a solid understanding of it either. Over half the states in the U.S.

Business 41

Business Oil Education Seed-To-Sale 41

Cannabis Law Report

MAY 5, 2022

Here are some of the drug claims referenced in the FDA Warning Letters: Facebook post stating “Delta-8 THC is showing a lot of promise as an antiemetic that can relieve nausea and vomiting in pediatric cancer patients undergoing chemotherapy.”. The FDA sets rigorous testing standards to establish a drug’s safety. Delta-8 in Food.

Food 52

Food THC CBD Research and Development 52

The Joint Blog

JANUARY 26, 2021

The good thing about CBD is that its side effects are infrequent and don’t require treatment. Why does it matter regarding safety? Sometimes, fake CBD bottles and packages might look identical to originals. This technology allows for maximum CBD potency and utmost safety. Sleepiness. Is CBD Legal? Certifications.

Oil 26

Oil CBD Chronic Pain Extraction 26

Kind Meds (Cannabis Education Blog)

MARCH 25, 2022

Cannabidiol as a Potential Treatment for Anxiety Disorders. According to Arizona law, valid patients are allowed to purchase up to an ounce of cannabis or 5 grams of extract or concentrate at a time. Most products on the sales floor of a dispensary are going to be packaged specifically and most likely even locked in a case.

Dispensary 52

Dispensary Edibles Strains Vaping 52

Cannabis Law Report

AUGUST 19, 2019

To date, only one cannabis-based medicinal product, Sativex, (for the treatment of multiple sclerosis) has been licensed by the MHRA. Under EU law, in the interests of safeguarding public health, novel foods must undergo a safety assessment before they can be authorised for placing on the market.

Environment 45

Environment Food Seed-To-Sale Medicine 45

CannaMD

MAY 14, 2020

CannaMD has contacted Florida’s leading medical marijuana treatment centers (MMTCs) , who say they’re now just waiting on the Department of Health to issue rules regarding packaging and other essential requirements. Safety of production and packaging. Risks of over-consumption and accidental ingestion.

Edibles 105

Edibles Marijuana THC Vaping 105

Cannabis Law Report

SEPTEMBER 23, 2019

Marijuana and related substance misuse are complex issues impacting family medicine, patient health, and public health. The AAFP urges its members to be involved in the diagnosis, treatment, and prevention of substance use, as well as secondary diseases impacted or caused by use. Relevant AAFP Policy. Call to Action.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Cannabis Law Report

JULY 1, 2021

In 2017, the FDA designated MDMA a breakthrough therapy for post-traumatic stress disorder, and in 2018 the agency recognized psilocybin as a breakthrough therapy for treatment-resistant depression. These designations indicate that psychedelics may represent substantial improvements over existing treatments for mental health conditions.

Law 105

Law Research and Development Therapy DEA 105

Puff Puff Post

NOVEMBER 5, 2019

INM-755 is a single-cannabinoid topical cream under development for the treatment of symptoms associated with epidermolysis bullosa (“EB”). It may also potentially address the underlying disease by enhancing skin integrity in a subset of EB Simplex patients. For more information, visit www.inmedpharma.com. About INM-755.

Clinical Trials 40

Clinical Trials Pharmaceutical Cannabinoids Data 40

SpeedWeed

JULY 19, 2021

The document in question was a 2020 safety study of the vape cartridge additive phytol. Certain vape additives are associated with lung injury, which shows up as cloudy on the left x-ray, and clear after treatment of one suspected VAPI patient in Utah. The data contained in that report has rocked the cannabis vaping world.

Vaping 52

Vaping Terpenes Data Research and Development 52

Healer

NOVEMBER 9, 2022

Over the years, I’ve determined that some of my adult patients experience therapeutic results with minimal to no adverse effects at oral doses as low as 1 mg of THC daily and as high as 1,000 mg or more daily. The majority of my patients use 2 mg to 30 mg of THC per dose. Be mindful of how much you’re taking, and be patient.

Tincture 105

Tincture Edibles Vaping THC 105

The Cannigma

MAY 15, 2023

Ketamine has a long safety record as an anesthetic since the 1980s, and it has also been successfully used “off-label” for over a decade to treat conditions such as anxiety, depression, OCD, and PTSD, among others. Patients may want to seek assistance from a certified professional prior to embarking on treatment.

Therapy 78

Therapy Access Blood Pressure Treatment 78

Cannabis Law Report

OCTOBER 29, 2019

ElleVet Sciences is pleased to announce the results and publication of the first safety study on the use of hemp CBD/CBDA. The 12-week safety study, conducted by Dr. Joseph Wakshlag, DVM, Ph.D., Dr. Wakshlag is currently available for interviews to discuss the results of the safety study as well as his clinical trials.

Safety 45

Safety CBD Clinical Trials Oil 45

Puff Puff Post

NOVEMBER 5, 2019

INM-755 is a single-cannabinoid topical cream under development for the treatment of symptoms associated with epidermolysis bullosa (“EB”). It may also potentially address the underlying disease by enhancing skin integrity in a subset of EB Simplex patients. For more information, visit www.inmedpharma.com. About INM-755.

Clinical Trials 8

Clinical Trials Pharmaceutical Cannabinoids Data 8

Cannabis Law Report

JULY 16, 2019

CCAs were created by the Medical and Adult-Use Cannabis Regulation and Safety Act (“MAUCRSA”). The Distributor adds costs of $500 and sells the packaged oil to a Dispensary for $1,800 plus the Dispensary’s payment to the Distributor of the associated CET of $432. A CCA can do everything a business corporation can do.

Agriculture 55

Agriculture Cultivation Dispensary Oil 55

The Cannigma

DECEMBER 22, 2021

It doesn’t mean, necessarily, that the market should go to full legalization within a year or two, because it won’t happen so fast, but you can have more patients with other medical indications that were not given cannabis before. Obviously, that means that there are more patients and there are more products to sell.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

Veriheal

DECEMBER 22, 2022

“Kentuckians suffering from chronic and terminal conditions are going to be able to get the treatment they need without living in fear of a misdemeanor,” Beshear said at the press conference, where two leading cabinet officials accompanied him. “Right now, there are no checks on how it’s packaged or sold.

THC 62

THC Conditions Policy Packaging 62

Cannabis Law Report

OCTOBER 17, 2019

Selinger cites software, point-of-sale systems, and packaging as areas that are thriving in the state. Many experts believe it can lead to beneficial treatments, reiterated in a report released by the National Academies of Sciences, Engineering, and Medicine in January 2017. alcoholic beverages, caffeine, and tobacco).

Law 40

Law Seed-To-Sale Hemp Recreational 40

Cannabis Law Report

SEPTEMBER 16, 2019

If the ruling stands, it could force the appropriate state officials to lift existing caps on how many medical marijuana treatment centers can operate in Florida. They also actively seek out cannabis products that are high quality, high-end and often artfully branded and packaged.”

Policy 63

Policy Legislation Research and Development Business 63